Call forwarding on iPhone is a simple feature with a specific job: it sends incoming calls from your iPhone number to another phone number. That can be useful when you are traveling, using a temporary phone, separating work and personal calls, covering a business line or making sure important calls reach someone else when you cannot answer.

The feature is built into iOS, but it depends on carrier support. Apple notes that call forwarding can be set up on iPhone if cellular service is through a GSM network. If the service uses a CDMA network, users may need to contact the carrier for setup details. That means the option may not appear for every user, every carrier or every plan.

For most supported iPhones, the path is quick:

Settings > Apps > Phone > Call Forwarding

Turn on Call Forwarding, then enter the phone number where calls should be sent. When call forwarding is active, an icon appears in the status bar so the user can see that incoming calls are being routed elsewhere.

Call Forwarding on iPhone Sends Calls Elsewhere

Call forwarding on iPhone does not move messages, FaceTime calls, app notifications or voicemail settings by itself. It only redirects standard cellular phone calls. If someone calls your iPhone number, the carrier routes that call to the number you entered.

That distinction is important. If you forward calls to another phone, text messages still arrive on the original iPhone unless other settings or services are involved. FaceTime calls may still ring on Apple devices signed into the same Apple Account. Messaging apps such as WhatsApp, Signal, Telegram or Messenger are unaffected.

Call forwarding is also different from Silence Unknown Callers, Focus modes or Do Not Disturb. Those features control how calls appear or interrupt you. Call forwarding changes where the call goes.

This makes the feature useful in a few common situations. A business owner can send calls to an office line. A traveler can forward calls to a local number. Someone with a damaged iPhone can temporarily send calls to another device. A freelancer can route calls to a partner during time off. A parent can forward calls to a spouse for a short period.

How to Turn On Call Forwarding

To turn on call forwarding:

• Settings > Apps > Phone > Call Forwarding
• Turn on Call Forwarding
• Tap Forward To
• Enter the phone number
• Go back to save the setting

Use the full phone number, including area code. If forwarding to an international number, include the correct country code. After setting it up, test the feature from another phone. Do not assume it works until a test call rings at the forwarded number.

To turn call forwarding off:

Settings > Apps > Phone > Call Forwarding > Turn off

After turning it off, test again. A quick call from another phone confirms whether incoming calls are back to normal.

If the Call Forwarding menu spins, fails to load or does not save the number, restart the iPhone and check cellular service. If the problem continues, contact the carrier because the setting depends on the carrier network.

Why the Setting May Be Missing

Some users look for call forwarding and cannot find it. That usually means one of three things: the carrier does not expose the feature in iPhone settings, the plan does not support it, or the network requires carrier codes or account-level setup.

Apple’s guide says CDMA users should contact their carrier for call forwarding information. Some carriers also use special dialing codes for forwarding all calls, forwarding when busy, forwarding when unanswered or forwarding when unreachable. Those codes vary by carrier and country, so guessing is not a good idea.

The best path is to check the carrier’s support page or app. Many carriers let users manage forwarding from the account dashboard, especially for business lines or multi-line plans.

If the option is missing, the iPhone is not necessarily broken. The carrier may simply handle forwarding differently.

What Happens to Voicemail

Call forwarding can affect voicemail behavior depending on the carrier and destination number. If the forwarded phone does not answer, the call may go to the voicemail of the forwarded number instead of the original iPhone voicemail. In some cases, carrier rules may still send it back to the original mailbox, but users should not assume that.

This is another reason to test. Call the iPhone from another number, let it ring, and see where the missed call lands. If the goal is to preserve the original iPhone voicemail, carrier support may be needed.

For work numbers, this can be especially important. A forwarded business call going to a personal voicemail greeting can look unprofessional. A personal call going to a shared office voicemail can create privacy problems. Check before relying on it.

Call Forwarding and Dual SIM

iPhone users with Dual SIM or eSIM setups should pay attention to which line is being forwarded. A personal line and business line can have separate carrier settings. Forwarding one does not automatically forward the other.

To check lines:

Settings > Cellular > Select the line you want to manage

Then return to:

Settings > Apps > Phone > Call Forwarding

The available settings may vary by carrier and line. If one line supports call forwarding and the other does not, that is usually a carrier difference, not an iPhone problem.

Dual SIM users should also test both numbers separately. Call the personal number, then call the business number, and confirm each behaves as expected.

When Call Forwarding Is Useful

Call forwarding works best when the goal is temporary coverage. It is useful during travel, device repairs, vacations, business handoffs, office moves, event coverage or times when another person needs to answer calls.

It can also help people who use a landline or desk phone during work hours. Calls can be forwarded from the iPhone to the office line, then turned off at the end of the day. The reverse can also work if the carrier supports it.

For small businesses, call forwarding can help avoid missed calls without adding a full phone system. A company can route calls to whoever is available. For individuals, it can be a quick fix when an iPhone battery is failing, a device is being repaired, or cellular reception is better on another phone.

The feature is less ideal as a permanent business phone solution. If multiple people need to answer calls, if calls need menus, if calls need recordings, or if voicemail needs to stay organized, a dedicated phone service may be better.

Privacy and Cost Considerations

Call forwarding may create charges depending on the carrier, plan and destination number. Forwarding calls to an international number can be expensive. Forwarding to another domestic mobile number is usually simpler, but users should still check the plan.

Privacy also deserves attention. Once calls are forwarded, the person or device receiving them may hear personal, business or sensitive conversations meant for the original number. Do not forward calls to a shared phone unless that is intentional.

Before forwarding a work line to a personal number, check company policy. Some organizations do not allow business calls to be routed to unmanaged personal devices.

How to Troubleshoot Call Forwarding

If call forwarding does not work, start with the basics. Confirm the iPhone has cellular service. Restart the device. Check that the forwarding number is entered correctly. Turn call forwarding off, wait a few seconds, then turn it on again.

Then test from another phone. A test call is the fastest way to know whether the carrier accepted the setting.

If calls still do not forward, check whether the carrier supports call forwarding through iPhone settings. Some carriers require account-level activation, carrier codes or a business calling feature. If the iPhone setting is missing or stuck, carrier support is usually the right next step.

Also check Focus modes and blocked numbers if the issue is not forwarding but missed calls. A call may fail to ring because of Focus, Silence Unknown Callers, a blocked contact, poor signal or voicemail settings rather than call forwarding.

A Simple Feature Worth Testing

Call forwarding on iPhone is easy to use when the carrier supports it. Open iPhone settings, turn on Call Forwarding, enter the destination number and test it. Turn it off when the temporary need is over.

The feature is most useful when it is deliberate and short-term. It can keep calls moving during travel, repairs, work coverage or busy periods, but it should be checked carefully because voicemail, costs and privacy can change once calls are routed to another number.

The iPhone makes the setting simple. The carrier decides how far that simplicity goes.

The post Call Forwarding on iPhone: How It Works appeared first on AppleMagazine.

This discounted lifetime license to Microsoft Office Home & Business for Mac 2024 is a great alternative to pricey monthly fees.

(via Cult of Mac - Your source for the latest Apple news, rumors, analysis, reviews, how-tos and deals.)

Cadmium (Cd) contamination is a growing threat to food safety, and rice is one of the most vulnerable crops. Because rice plants can accumulate cadmium from contaminated soils more readily than many other staples, Cd can become a major dietary exposure route for large parts of the world’s population. Yet attempts to lower cadmium often create trade-offs—reducing uptake of essential nutrients or weakening plant performance.

A new study from Okayama University, Japan, and collaborating researchers in China reports a precision-editing strategy designed to avoid those trade-offs. The team focused on the rice metal transporter gene OsNramp5, which is known to move metals such as manganese and cadmium, and used base-editing to search for a beneficial point mutation within the gene rather than disabling it.

Using adenine and cytosine base editors, the researchers generated more than 1,600 genome-edited rice lines and screened them for reduced cadmium accumulation. Their saturation mutagenesis approach targeted OsNramp5 to identify variants that kept normal plant physiology while limiting Cd buildup in grain.

The key breakthrough was the I441T substitution: changing isoleucine to threonine at amino acid position 441. This single change reduced cadmium levels in both shoots and brown rice without altering gene expression, protein abundance, or the subcellular localization of the transporter.

Importantly, the mutation did not come at the cost of micronutrients. Field trials on cadmium-contaminated soil showed a 48% decrease in cadmium concentration in brown rice, from 0.14 mg/kg in wild type to 0.07 mg/kg in the edited plants, while iron, manganese, and zinc levels remained essentially unchanged.

The researchers then explored the mechanism behind the selective effect. Although OsNramp5 transports multiple metals, the I441T mutation shifted its selectivity—enhancing zinc transport preference. Increased zinc accumulation in root cells promoted competitive inhibition against cadmium during root-to-shoot movement.

Instead of completely blocking cadmium uptake, the edited transporter selectively limited cadmium translocation, reducing grain contamination while preserving essential mineral delivery. The team supported these conclusions with physiological assessments, gene and protein analyses, yeast transport assays, and agronomic evaluation.

Overall, the work demonstrates how precision genome editing can address a long-standing breeding challenge: lowering toxic metal accumulation without disrupting nutrient homeostasis. The researchers propose that the OsNramp5^I441T allele could accelerate development of safer rice varieties for mildly contaminated regions.

Subject of Research: Not applicable
Article Title: Genome-edited rice variety with low-cadmium accumulation in the grain
News Publication Date: 18-Jun-2026
Web References: http://dx.doi.org/10.1073/pnas.2610609123
References: DOI: 10.1073/pnas.2610609123 (Proceedings of the National Academy of Sciences)
Image Credits: Credit: Professor Jian Feng Ma from Okayama University, Japan

Keywords: cadmium, rice, OsNramp5, base editing, genome editing, metal transporters, food safety, micronutrients, zinc competition, plant breeding

I’m sick of “opt-out” toggles for automatically enabled generative AI features. It’s past time to make “opt in” the default setting for sensitive features.

I’m sick of “opt-out” toggles for automatically enabled generative AI features. It’s past time to make “opt in” the default setting for sensitive features.

No, there weren't "2,700 heatwave deaths due to climate change", says Ben Pile – a figure conjured by Met Office and Imperial College modelling. But nobody must be allowed to remember the warm days of 2026 fondly.

The post No, There Weren’t “2,700 Heatwave Deaths Due to Climate Change” appeared first on The Daily Sceptic.

The end of the FIFA Men’s World Cup is nigh. Here’s how to watch the final games and the first ever World Cup halftime show.

Pig executions helped medieval communities punish negligence, display power and restore a threatened social order.

If you want to stream local media, this free and open source media server is just as good as Plex. But if you rely on remote access or live TV, prepare to tinker.

Did you know that the space shuttle once launched the Statue of Liberty into space?

In fact, there were two "Lady Liberties" on board Discovery when it lifted off on its fourth flight in April 1985. To be fair, each statue was only 15 inches tall (38.1 centimeters), but they were also each made of copper that was removed from the full-size statue during its then-still-ongoing restoration.

After the weeklong STS-51D mission was over, one of the space-flown statues was placed on display, and the other was melted down to create copper seals, which were then sold to the public by the Statue of Liberty Ellis Island Centennial Commission.

Read full article

Comments

© collectSPACE.com

Schistosoma mansoni is a parasitic worm that infects millions of people worldwide, entering the body through the skin. Unlike bacterial infections that often cause pain and inflammation, S. mansoni usually slips in unnoticed, rarely causing discomfort. Scientists have long wondered why our skin’s defenses don’t react more strongly to this invader.

Researchers from the University of Pennsylvania and Tulane University explored whether a specialized group of pain-sensing neurons, called TRPV1+, plays a role in detecting and fighting off S. mansoni during its invasion. TRPV1+ neurons are nerve cells in the skin that respond to heat, spicy foods, and certain bacteria and fungi. When activated, they can trigger pain and release molecules that alert the immune system. Previous researchers have shown that these neurons help defend against bacterial and fungal skin infections, but their role in fighting off parasites was unclear. 

To examine how S. mansoni infects its hosts, the team conducted experiments using groups of 4 to 8 mice, matched for age and sex. They repeated each experiment 2 to 3 times to ensure their data was reproducible. They anesthetized the mice, exposed their ears to a solution containing 100 to 150 live S. mansoni larvae, and covered the area with vaseline to keep the solution in place. After 20 to 30 minutes, they counted the number of larvae remaining in the mice’s ears to assess how many had successfully penetrated their skin. 

Next, the team measured pain sensitivity in the mice exposed to the parasite by placing them in chambers and applying an infrared heat source to their paws. They recorded how long it took each mouse to withdraw its paw as a sign of pain. They repeated this test 3 times per paw on each mouse, waited at least 5 minutes between each measurement, and calculated an average withdrawal time. They found that mice infected with S. mansoni were approximately half as sensitive to heat-induced pain as an uninfected control group, suggesting that the parasite could be suppressing the mice’s TRPV1+ neurons.

To investigate this further, the team isolated nerve cells that transmit sensory signals from the mice’s skin, known as dorsal root ganglia, and grew them in the lab. They stimulated these neurons by adding a spicy compound in chili peppers, known as capsaicin. Then they measured calcium influx, a sign the neurons were active, using a special dye that glows differently under a microscope depending on calcium levels. This allowed them to see how active the neurons were and how many molecules they released in response to infection and stimulation. They found that 68% of neurons from uninfected mice responded to capsaicin, but only 26% of neurons from infected mice did so, confirming that the parasite dampened their sensory neuron responses.

To test whether restoring the mice’s neuron activity could help their bodies resist parasite invasion, the researchers genetically engineered the mice to produce a light-sensitive protein in their TRPV1+ neurons, called channelrhodopsin. They “turned on” these neurons by stimulating them with blue light for 30 minutes every day for 5 days before infecting the mice with parasites. Six days later, they assessed the mice’s immune response by using a laser to count immune cells in samples of ear tissue. They also determined how far the parasites had spread by counting larvae in lung samples. They saw that mice with the artificially activated TRPV1+ neurons had nearly double the immune response, blocked roughly twice as many larvae at the skin, and had about 20% fewer parasites in their lungs.

Next, the researchers selectively destroyed TRPV1+ neurons in a new set of mice using a compound known as resiniferatoxin. Three weeks later, they confirmed the treatment had worked by testing the mice’s pain sensitivity using the same heat assay as before. After confirming the mice had lost their pain sensitivity, the team exposed the mice to the parasites. They found that the reinfected mice had 1% to 3% weaker skin immune responses and approximately 25% to 30% more parasites in their lungs than a control group, further confirming that TRPV1+ neurons play a protective role during early infection.

The team concluded that S. mansoni has evolved ways to silence pain-sensing neurons, like TRPV1+. Their discovery suggests that future scientists could boost skin immunity against parasites by targeting sensory neurons. For example, they could develop topical creams or therapies that activate these neurons to help our bodies fight off S. mansoni and similar parasitic invaders.

The post A parasite that numbs your pain appeared first on Sciworthy.

The government is teaming up with Colossal Biosciences, a private company that claims to have revived extinct dire wolves, to store samples from at-risk animals and plants.

© Lenny Ignelzi/Associated Press

In the rapidly evolving field of geroscience, the quest to translate scientific breakthroughs into tangible clinical benefits has encountered a formidable obstacle: the challenge of selecting trial outcomes that comprehensively reflect the multifaceted effects of geroprotective interventions while satisfying rigorous clinical and regulatory benchmarks. Despite the surge in research advancing our understanding of aging and potential therapies to extend healthspan, clinical trials often struggle to identify endpoints that are simultaneously robust, feasible, and accepted by regulators. This conundrum has impeded the pace at which promising discoveries transition from the bench to bedside.

Traditional endpoints in clinical trials for aging-related therapies have heavily relied on mortality as the gold standard outcome. Mortality is undeniably objective and resonates with regulatory agencies due to its clear clinical significance. However, using mortality as a primary endpoint is frequently impractical in geromedicine trials. The extended timelines required, the large participant populations needed, and ethical considerations make mortality a difficult measure for many intervention studies focused on aging. Given the complexity and prolonged nature of aging processes, mortality-based outcomes often limit the feasibility of clinical research into interventions designed to slow or reverse age-associated decline.

As an alternative, surrogate measures aimed at capturing the quality of extended life, often termed healthspan, have gained attention. Healthspan encompasses diverse dimensions such as physical function, cognitive performance, and biomarker profiles that collectively reflect an individual’s biological and functional status. These measures present a more practical and nuanced depiction of aging’s trajectory and the impact of geroprotective treatments. Nevertheless, healthspan-related endpoints are frequently regarded as “soft” or indirect, necessitating further validation to convince stakeholders of their reliability and clinical relevance. Their subjective nature and variability introduce challenges in affirming their predictive value and regulatory acceptance.

In response to these challenges, researchers have proposed an innovative methodological framework that seeks to harmonize the strengths of both mortality and healthspan measures while mitigating their respective weaknesses. This novel strategy employs hierarchical composite endpoints analyzed through a time-to-worst-event approach, leveraging win statistics to facilitate a pragmatic and scientifically grounded compromise. The essence of this methodology lies in comparing participant pairs within clinical trials based on a predefined, clinically justified hierarchy of events, prioritizing the most severe and objective endpoints such as mortality and major morbidity.

This hierarchical design assigns differing weights to outcomes positioned along a clinical severity spectrum. At the highest tier reside unequivocal events—death and serious clinical incidents—that carry unquestionable clinical importance and regulatory weight. Subsequent tiers integrate healthspan surrogates and biomarker data, contributing valuable subsidiary information that captures subtler yet meaningful intervention effects. Employing this layered approach enables researchers to reflect a fuller spectrum of aging-related outcomes without compromising the prominence of critical clinical endpoints.

Time-to-worst-event analysis serves as a robust statistical tool within this hierarchical framework. By focusing on the timing of the most severe event experienced by an individual, the methodology ensures that the earliest and most significant detriment determines the outcome classification, encompassing the patient’s clinical journey comprehensively. This time-sensitive lens captures not only whether but also when adverse clinical states manifest, providing a dynamic and nuanced perspective critical for aging-related trials, where the temporal dimension is essential.

Central to the proposed framework is the use of “win statistics,” a comparative metric allowing pairwise analysis of trial participants. This statistical method calculates wins, ties, and losses based on the clinical hierarchy, elucidating the overall treatment effect by aggregating these individual pairwise comparisons. The win statistic’s strength lies in its ability to synthesize multifaceted outcomes into a single interpretable measure while maintaining clinical meaning and relevance. Unlike conventional single-endpoint analyses, this approach acknowledges the multidimensional impact of geroprotective interventions.

Importantly, the selection and ordering of outcomes within this hierarchical system demand rigorous clinical and mechanistic justification. Consensus must be achieved among investigators, clinicians, and regulatory authorities to define which events take precedence and how ties are resolved. This transparent and collaborative process assures that composite endpoint construction reflects true clinical priorities and biological plausibility, bolstering regulatory confidence and facilitating trial approval and interpretation. Such an approach safeguards against arbitrary outcome weighting or biased interpretation.

The implications for the future of geromedicine clinical trials are substantial. By embracing hierarchical composite endpoints and win statistics, researchers can design more efficient trials that capture a broad spectrum of treatment effects within feasible timescales and participant cohorts. This methodology sidesteps the pitfalls of relying solely on mortality, while strengthening the evidentiary value of surrogate endpoints and biomarkers. Consequently, promising geroprotective interventions may undergo more straightforward, cost-effective evaluation, accelerating their clinical translation and potential public health impact.

This innovative design also opens pathways for more personalized assessment of intervention efficacy. By integrating multiple health domains and clinical events, trials can better reflect the heterogeneity of aging populations and diverse therapeutic mechanisms. The nuanced outcome assessment permits differential benefits and risks to be dissected, fostering precision geromedicine. Regulators and clinicians alike stand to gain from richer and more actionable data that truly capture quality-of-life improvements alongside traditional survival metrics.

Moreover, the potential regulatory acceptance of hierarchical composite endpoints could catalyze a paradigm shift in aging-related drug development. As the geroscience community demonstrates the validity and utility of such outcomes, regulators may become more amenable to approving longevity therapeutics supported by multifaceted endpoints rather than awaiting protracted mortality data. This regulatory evolution promises to invigorate investment and innovation in geromedicine, an area of growing importance in the context of expanding elderly populations worldwide.

While promising, this approach also entails challenges. It requires meticulous endpoint definition and standardization, robust statistical modeling expertise, and extensive stakeholder engagement to ensure that composite hierarchies are clinically meaningful and mechanistically grounded. Ensuring reproducibility and cross-trial comparability necessitates development of consensus guidelines and open data standards. Ethical considerations surrounding the relative weighting of life quality versus survival further complicate endpoint formulation and require ongoing discourse.

Nevertheless, the proposed hierarchical endpoint framework with win statistics embodies a timely and much-needed advancement addressing a fundamental bottleneck in geroscience clinical research. By bridging regulatory requirements with scientific insights into aging’s multidimensional nature, it lays a robust foundation for accelerated translation of geroprotective therapies. As the population demographic shift intensifies demand for effective aging interventions, such pioneering statistical and clinical innovation is pivotal in transforming geromedicine from promising science into practical medicine.

The work by Abdellatif, Kim, and Kroemer offers a compelling blueprint for the next generation of geromedicine trials. Their integrative approach thoughtfully balances objectivity, clinical relevance, and feasibility, paving the way for interventions that not only extend lifespan but also enhance the quality of those extended years. The advent of hierarchical composite endpoints guided by win statistics may ultimately revolutionize how aging therapies are evaluated, deployed, and embraced by healthcare systems worldwide, heralding a new era in age-related healthcare.

As this methodology gains traction, collaborative efforts across academia, industry, and regulatory bodies will be critical to refine, validate, and implement hierarchical endpoints in ongoing and future geroscience trials. Real-world application and longitudinal data will provide further insights to optimize outcome hierarchies and better reflect patient-centered benefits. Such collective progress holds the promise to unlock the full potential of geroprotective interventions, reshaping the landscape of aging medicine.

In essence, hierarchical composite endpoints and win statistic analysis emerge as a paradigm-shifting solution to the age-old dilemma of measuring meaningful outcomes in aging research. By embracing complexity and clinical priorities simultaneously, this approach captures the multidimensional health impacts of geromedicine interventions with rigor and pragmatism. The coming years will reveal how this innovation transforms clinical trial design and ultimately delivers on the long-awaited promise of prolonging both lifespan and healthspan.

---

Subject of Research: Geroscience clinical trial outcome measurement; hierarchical composite endpoints in geromedicine studies; win statistics for multidimensional aging-related outcomes

Article Title: Hierarchical endpoints and win statistics for geromedicine trials

Article References:
Abdellatif, M., Kim, Y. & Kroemer, G. Hierarchical endpoints and win statistics for geromedicine trials. Nat Aging (2026). https://doi.org/10.1038/s43587-026-01158-3

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s43587-026-01158-3

Asylum accommodation costs have more than trebled to over £15 billion and made a billionaire out of Clearsprings owner Graham King. This scandalous racket needs to end, says Madeleine Gillies.

The post Asylum Accommodation is Ripping off the Taxpayer  appeared first on The Daily Sceptic.

Do you crave speedy, reliable Wi-Fi throughout your home? Snag one of these Prime Day router or mesh deals.

Do you crave speedy, reliable Wi-Fi throughout your home? Snag one of these Prime Day router or mesh deals.

There’s no better time to get a Kindle than during Amazon's own sale event.

There’s no better time to get a Kindle than during Amazon's own sale event.

In a supposed “nationwide first” use of drones to disarm a person, the Sacramento County Sheriff’s Office in California promoted a video showing how a small quadcopter drone used a dangling magnet to remove a knife from the hand of a motionless suspect.

The promotional video shared to Facebook and Instagram on June 22, 2026, uses the Mission: Impossible film franchise theme to dramatize video footage of the incident that took place earlier in the month, which involved what the video describes as a “felony suspect armed with a knife and a firearm” who “was not responding to negotiators.” The sheriff’s office is just one among hundreds of US police departments and sheriff’s offices that have deployed camera-equipped drones to assist first responders.

In a Facebook post, the Sacramento County Sheriff’s Office described having surrounded the suspect’s residence with a SWAT team after the “known felon and parolee-at-large was seen earlier with a firearm.” A first drone deployed to the scene located the suspect hiding in a corner of the garage, but also spotted the motionless suspect holding a knife in one outstretched arm.

Read full article

Comments

© Sacramento County Sheriff’s Office

In a supposed “nationwide first” use of drones to disarm a person, the Sacramento County Sheriff’s Office in California promoted a video showing how a small quadcopter drone used a dangling magnet to remove a knife from the hand of a motionless suspect.

The promotional video shared to Facebook and Instagram on June 22, 2026, uses the Mission: Impossible film franchise theme to dramatize video footage of the incident that took place earlier in the month, which involved what the video describes as a “felony suspect armed with a knife and a firearm” who “was not responding to negotiators.” The sheriff’s office is just one among hundreds of US police departments and sheriff’s offices that have deployed camera-equipped drones to assist first responders.

In a Facebook post, the Sacramento County Sheriff’s Office described having surrounded the suspect’s residence with a SWAT team after the “known felon and parolee-at-large was seen earlier with a firearm.” A first drone deployed to the scene located the suspect hiding in a corner of the garage, but also spotted the motionless suspect holding a knife in one outstretched arm.

Read full article

Comments

© Sacramento County Sheriff’s Office